Univariate and multivariate analyses for progression-free survival.
- Eduardo Díaz-Rubio (303102)
- Auxiliadora Gómez-España (303104)
- Bartomeu Massutí (303106)
- Javier Sastre (303108)
- Margarita Reboredo (303109)
- José Luis Manzano (303112)
- Fernando Rivera (225591)
- MªJosé Safont (303116)
- Clara Montagut (303119)
- Encarnación González (303122)
- Manuel Benavides (303125)
- Eugenio Marcuello (303128)
- Andrés Cervantes (303131)
- Purificación Martínez de Prado (303133)
- Carlos Fernández-Martos (303134)
- Antonio Arrivi (303135)
- Inmaculada Bando (303136)
Publication date
February 2013
DOIAbstract
<p>Abbreviations: AP, alkaline phosphatase; bev, bevacizumab; CI, confidence interval; ECOG PS, Eastern Cooperative Oncology Group performance status; HR, hazard ratio; LDH, lactate dehydrogenase; MT, mutant type; WT, wild type; XELOX, capecitabine + oxaliplatin.</p
Add to ORKG